Reports

Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025
Global Cancer Tumor (Organoids) "Modeling", Technology - & Personalized Cancer Research Insight 2025
Published
Number of pages
250

"Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025" Report Highlights: Application of Organoids by Cancer Therapeutic CRISPR-Cas9 Potential Applications in Cancer Organoids Cancer Organoid Market Opportunity Assessment: >US$ 400 Million Clinical Trials Registered under Cancer Organoids Personalized Cancer Therapy Using Cancer Organoids Joint Ventures to Accelerate Drug Discovery through Organoids The development of cancer organoids has transformed the widespread adoption of the traditional 2D cell lines in the research community. The technology of cancer organoids holds a significant potential to study variety of areas such as cancer disease pathology, cancer biology, precision medicine, drug development, drug

Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026
Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026
Published
Number of pages
510

"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: Global Bispecific Antibody Market Opportunity: > US$ 10 Billion Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) Global Bispecific Antibody Pipeline: 333 Drug Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra) Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & > 80% “Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026” provides comprehensive insight on clinical and non-clinical factors that are driving the global bispecific antibodies market and

Reports
Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026
Published
Number of pages
2400

"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: Global Orphan Drug Market Opportunity: US$ 300 Billion US Dominates Global Orphan Drug Market: 50% Market Share US Orphan Drug Opportunity To Surpass: US$ 150 Billion Global Orphan Drug Clinical Insight: More Than 900 Drugs Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs Oncology To Dominate Orphan Drug Development: 35% Share FDA & EMA Regulations For Orphan Drugs Orphan Drug Designation Criteria & Reimbursement Policy by Country The research report “Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026” discusses about the recent trends and

Reports
Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026
Published
Number of pages
1500

"Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlight: Global Gene Therapy Market Opportunity: > US$ 8 Billion Global Gene Therapy Clinical Pipeline: > 1000 Therapies In Clinical Trials Commercially Available Gene Therapies: 11 USA Dominates Global Gene Therapy Pipeline: > 500 Therapies In Clinical Trials Cancer Accounts For 50% of Global Gene Therapy Trials The potential of gene therapy approach to address the diseases that are unable to get treated with any other treatment is quickly becoming a reality and the approval of gene therapy products for the commercial use is seeking for a fascinating breakthrough

Reports
Global Parkinsons Drug Market & Clinical Trial Insight 2025
Published
Number of pages
500

"Global Parkinson\'s Drug Market & Clinical Trial Insight 2025" Report Highlights: Global Parkinson\'s Disease Prevalence & Statistics Global Parkinson\'s Drug Market Opportunity: US$ 8 Billion Parkinson\'s Drug Clinical Pipeline: >250 Drugs Clinical Insight on Marketed Parkinson\'s Drug: 30 Drugs Anti-Parkinson\'s Drugs - Availability, Dosage & Price Analysis In-Depth Insight on More Than 250 Drugs In Clinical Trials The parkinson\'s drug market is currently witnessing exponential growth and emerging as a huge therapeutic market segment with unexplored potential. Presence of a vast variety of therapeutics as well as development of new approaches for management of parkinson\'s disease is indicating towards a

Reports
Global Breast Cancer Drug Market & Clinical Trial Insight 2025
Published
Number of pages
1200

" Global Breast Cancer Drug Market & Clinical Trial Insight 2025" Report Highlights: Global Breast Cancer Drug Market: US$ 40 Billion Opportunity Global Breast Cancer Drug Clinical Pipeline: More Than 550 Drugs Marketed Breast Cancer Drugs: More Than 90 Drugs Clinical Insight On More Than 550 Drugs In Clinical Trials Comprehensive Clinical Insight & Patent Information Drug Trials, Pricing, Dosage, Cancer Prevalence Insight: 130 Graphs/Charts The applied science research has marked tremendous advancements in cutting off the epidemic cancer scenarios all around the world but every year unexpectedly more than one million new cases of breast cancer are reported. Breast

Reports
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026
Published
Number of pages
1500

“Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: Global Peptide Therapeutics Market Opportunity: US$ 65 Billion Peptide Therapeutics Market Opportunity: US$ 22 Billion Insight Peptide Drugs in Clinical Trials: 807 Peptides Drugs Clinical & Patent Insight on 197 Marketed Peptides Peptide Clinical Pipeline Is Dominated by Cyclic Peptides: 46 Peptides Peptides Clinical Trials Insight by Phase, Indication & Company Future Peptide Therapeutics Market Outlook “Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report gives comprehensive insight on clinical and non-clinical parameters involved in the development of global peptide drug market. As per report findings, peptides have

Reports
Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024
Published
Number of pages
1100

" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: Significance for Monoclonal Antibodies for Cancer Treatment Global Cancer Monoclonal Antibodies Market Overview Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication Global Cancer Monoclonal Antibodies Pipeline: 697 mAb Marketed Cancer Monoclonal Antibodies: 60 Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion The recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to

Reports
Global Cancer Vaccine Market & Clinical Trial Insight 2025
Published
Number of pages
700

"Global Cancer Vaccine Market & Clinical Trial Insight 2025" Report Highlight: Global Cancer Vaccine market Opportunity: US$ 15 Billion opportunity Personalized Cancer Vaccine: The Next growth Frontier Global Cancer Vaccine Clinical insight by Indication & Phase of Development Global Cancer Vaccine Pipeline: 369 Cancer Vaccines Marketed Cancer Vaccines: 17 Cancer Vaccines Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines Regulatory Landscape Global cancer vaccine market opportunity is expected to surpass US$ 15 Billion by 2025 as per finding in new research report “Global Cancer Vaccine Market & Clinical Trial Insight 2025” published by PNS Pharma. In

Reports
Global Orphan Drug Pipeline & Regulatory Insight 2025
Published
Number of pages
2200

" Global Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per recent research report \"Global Orphan Drug Pipeline & Regulatory Insight 2025\" published by PNS Pharma. The orphan drug segment has emerged as a new growth frontier